Transfusion-related acute lung injury

Blood

Volumn 105, Issue 6, 2005, Pages 2266-2273

  Silliman, Christopher C ^a   Ambruso, Daniel R ^b   Boshkov, Lynn K ^b  

^a Bonfils Blood Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; GRANULOCYTE ANTIBODY; HLA ANTIBODY;

ANIMAL MODEL; ANTIGEN EXPRESSION; BLOOD COMPONENT; CAPILLARY LEAK SYNDROME; CAUSE OF DEATH; CELL ACTIVATION; HUMAN; INCIDENCE; LEUKOCYTE; LUNG ENDOTHELIUM; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSFUSION RELATED ACUTE LUNG INJURY; UNITED STATES;

EID: 15244343326     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-07-2929     Document Type: Review

References (104)

1. Barnard RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med. 1951;51:2399-2402.
2. Brittingham TE, Chaplin H Jr. Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. JAMA. 1957;165:819-825.
3. Philipps E, Fleischner FG. Pulomonary edema in the course of a blood transfusion without overloading the circulation. Dis Chest. 1966;50:619-623.
4. Ward HN. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med. 1970;73:689-694.
5. Thompson JS, Severson CD, Parmely MJ, Marmorstein BL, Simmons A. Pulmonary "hypersensitivity" reactions induced by transfusion of non-HL-Aleukoagglutinins. N Engl J Med. 1971;284:1120-1125.
6. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25:573-577.
7. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev. 2004;18:184-188.
8. Fisk J, Snyder E, Blajchman MA. Transfusion-related acute lung injury. The Hematologist: ASH News and Reports 1[3], 4. 2004. Washington, DC: American Society of Hematology.
9. Popovsky MA. Transfusion related acute lung injury. In: Popovsky MA, ed. Transfusion Reactions. Bethesda, MD: American Association of Blood Banks Press; 2001.
10. Kopko PM. Review: transfusion-related acute lung injury: pathophysiology, laboratory investigation, and donor management. Immunohematology. 2004;20:103-111.
11. Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion. 1997; 37:719-726.
12. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101:454-462.
13. Technical Manual. 14th ed. Bethesda, MD: American Association of Blood Banks; 2002.
14. Wallis JP. Transfusion-related acute lung injury (TRALI)-under-diagnosed and under-reported. Br J Anaesth. 2003;90:573-576.
15. Covin RB, Ambruso DR, England KM, et al. Hypotension and acute pulmonary insufficiency following transfusion of autologous red blood cells during surgery: a case report and review of the literature. Transfus Med. 2004;14:375-383.
16. Bernard GR, Artigas A, Brigham KL, et al. Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination: Consensus Committee. J Crit Care. 1994;9:72-81.
17. Kopko PM, Popovsky MA, MacKenzie MR, et al. HLA class II antibodies in transfusion-related acute lung injury. Transfusion. 2001;41:1244-1248.
18. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA. 2002;287:1968-1971.
19. Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol. 1999;105:322-329.
20. Silliman CC. Transfusion-related acute lung injury. Transfus Med Rev. 1999;13:177-186.
21. Nouraei SM, Wallis JP, Bolton D, Hasan A. Management of transfusion-related acute lung injury with extracorporeal cardiopulmonary support in a four-year-old child. Br J Anaesth. 2003;91:292-294.
22. Fowler AA, Hamman RF, Good JT, et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983;98:593-597.
23. Kao GS, Wood IG, Dorfman DM, Milford EL, Benjamin RJ. Investigations into the role of anti-HLA class II antibodies in TRALI. Transfusion. 2003;43:185-191.
24. Kollef MH, Schuster DP. The acute respiratory distress syndrome. N Engl J Med. 1995;332:27-37.
25. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982;144:124-130.
26. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101:1458-1467.
27. Popovsky MA. Transfusion-related acute lung injury. In: Popovsky MA, ed. Transfusion Reactions. Bethesda, MD: American Association of Blood Banks Press; 1996:167-183.
28. Popovsky MA. Breathlessness and blood: a combustible combination. Vox Sang. 2002;83(suppl 1):147-150.
29. Vamvakas EC. Allergic and anaphylactic reactions: In: Popovsky MA, ed. Transfusion Reactions. Bethesda, MD: American Association of Blood Banks Press; 1996:81-124.
30. Hillyer CD, Josephson CD, Blajchman MA, et al. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology (Am Soc Hematol Ed Program). 2003;575-589.
31. Robillard P, Nawej KI, Chapdelaine A, Poole J, Garneau N. Adverse transfusion reactions with respiratory signs and symptoms including TRALI in the Quebec Hemovigilance System: 2000-2003 [abstract]. Transfusion. 2004;44:23.
32. Renaudier PC, Vo Mai MP, Azanowsky JM, et al. Epidemiology of transfusion related acute lung injury in Gifit, the Frech Hemovigilance Database: a study of the French Hemovigilance Network [abstract]. Transfusion. 2004;44:23.
33. Wallis JP, Lubenko A, Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion. 2003;43:1053-1059.
34. Andreu G, Morel P, Forestier F, et al. Hemovigilance Network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion. 2002;42:1356-1364.
35. Stainsby D. Estimate of transfusion-related acute lung injury incidence is not supported by UK data [abstract]. Vox Sang. 2003;85:124.
36. Van Buren NL, Stroncek DF, Clay ME, McCullough J, Dalmasso AP. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion. 1990; 30:42-45.
37. Rabinovici R, Bugelski PJ, Esser KM, et al. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J Appl Physiol. 1993;74:1791-1802.
38. Salzer WL, McCall CE. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest. 1990;85:1135-1143.
39. Roffey P, Thangathurai D, Mikhail M, Riad M, Mogos M. TRALI and massive transfusion [abstract]. Resuscitation. 2003;58:121.
40. Medeiros BC, Kogel KE, Kane MA. Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma. Transfus Apheresis Sci. 2003;29:25-27.
41. Cooling L. Transfusion-related acute lung injury. JAMA. 2002;288:315-316.
42. Askari S, Nollet K, Debol SM, Brunstein CG, Eastlund T. Transfusion-related acute lung injury during plasma exchange: suspecting the unsuspected. J Clin Apheresis. 2002;17:93-96.
43. Bray RA, Harris SB, Josephson CD, Hillyer CD, Gebel HM. Unappreciated risk factors for transplant patients: HLA antibodies in blood components. Hum Immunol. 2004;65:240-244.
44. Davoren A, Curtis BR, Shulman IA, et al. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion. 2003;43:641-645.
45. Dykes A, Smallwood D, Kotsimbos T, Street A. Transfusion-related acute lung injury (TRALI) in a patient with a single lung transplant. Br J Haematol. 2000;109:674-676.
46. Ganguly S, Carrum G, Nizzi F, Heslop HE, Popat U. Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemia. Am J Hematol. 2004;75:48-51.
47. Leach M, Vora AJ, Jones DA, Lucas G. Transfusion-related acute lung injury (TRALI) following autologous stem cell transplant for relapsed acute myeloid leukaemia: a case report and review of the literature. Transfus Med. 1998;8:333-337.
48. Li GS, Ye QF, Xia SS, et al. Acute respiratory distress syndrome after liver transplantation: etiology, prevention and management. Hepatobiliary Pancreat Dis Int. 2002;1:330-334.
49. Urahama N, Tanosaki R, Masahiro K, et al. TRALI after the infusion of marrow cells in a patient with acute lymphoblastic leukemia. Transfusion. 2003; 43:1553-1557.
50. Yost CS, Matthay MA, Gropper MA. Etiology of acute pulmonary edema during liver transplantation: a series of cases with analysis of the edema fluid. Chest. 2001;119:219-223.
51. Boshkov LK, Maloney J, Bieber S, Silliman CC. Two cases of TRALI from the same platelet unit: implications for pathophysiology and the role of PMNs and VEGF [abstract]. Blood. 2000;96:655.
52. Bastit D, Cavelier B, Ropartz C. "White lung" during granulocyte transfusion: possible role of leukoagglutinins [in French]. Nouv Presse Med. 1982;11:2156-2157.
53. Karp DD, Ervin TJ, Tuttle S, et al. Pulmonary complications during granulocyte transfusions: incidence and clinical features. Vox Sang. 1982;42:57-61.
54. O'Connor JC, Strauss RG, Goeken NE, Knox LB. A near-fatal reaction during granulocyte transfusion of a neonate. Transfusion. 1988;28:173-176.
55. Rizk A, Gorson KC, Kenney L, Weinstein R. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion. 2001;41:264-268.
56. Behzadian MA, Windsor LJ, Ghaly N, et al. VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB J. 2003;17:752-754.
57. Cao R, Eriksson A, Kubo H, et al. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res. 2004;94:664-670.
58. Fu BM, Shen S. Acute VEGF effect on solute permeability of mammalian microvessels in vivo. Microvasc Res. 2004;68:51-62.
59. Yamazaki Y, Takani K, Atoda H, Morita T. Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J Biol Chem. 2003;278:51985-51988.
60. Muczynski KA, Cotner T, Anderson SK. Unusual expression of human lymphocyte antigen class II in normal renal microvascularendothelium. Kidney Int. 2001;59:488-497.
61. Riesbeck K, Billstrom A, Tordsson J, et al. Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells. Clin Diagn Lab Immunol. 1998;5:675-682.
62. Waldman WJ, Knight DA, Adams PW, Orosz CG, Sedmak DD. In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells. Transplantation. 1993; 56:1504-1512.
63. Gans RO, Duurkens VA, van Zundert AA, Hoomtje SJ. Transfusion-related acute lung injury. Intensive Care Med. 1988;14:654-657.
64. Yomtovian R, Kline W, Press C, et al. Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophil-specific antibody. Lancet. 1984;1:244-246.
65. Boshkov LK. Transfusion-associated acute lung injury (TRALI): an evolving understanding of the role of anti-leukocyte antibodies. Vox Sang. 2002; 83(suppl1):299-303.
66. Popovsky MA, Chaplin HC, Jr, Moore SB. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion. 1992;32:589-592.
67. Seeger W, Schneider U, Kreusler B, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood. 1990;76:1438-1444.
68. Bux J, Becker F, Seeger W, et al. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol. 1996;93:707-713.
69. Bux J, Hardt O, Kohstall M, Sibelius U, Weissmann N. Reproduction of granulocyte antibody-mediated TRALI in an ex-vivo rat lung model [abstract]. Blood. 2003;102:94.
70. Nicolle AL, Chapman CE, Carter V, Wallis JP. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Transfus Med. 2004;14:225-230.
71. Klein JB, McLeish KR, Ward RA. Transplantation, not dialysis, corrects azotemia-dependent priming of the neutrophil oxidative burst. Am J Kidney Dis. 1999;33:483-491.
72. Partrick DA, Moore EE, Fullerton DA, et al. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J Surg Res. 1999; 86:42-49.
73. Ward RA, McLeish KR. Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif Organs. 1995;19:801-807.
74. Varela M, Mas A, Nogues N, et al. TRALI associated with HLA class II antibodies [abstract]. Transfusion. 2002;42:1102.
75. Win N, Brown C, Navarrete C. TRALI associated with HLA class II antibodies. Transfusion. 2003;43:545-546.
76. Kopko PM, Paglieroni TG, Popovsky MA, et al. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion. 2003;43:177-184.
77. Gosselin EJ, Wardwell K, Rigby WF, Guyre PM. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol. 1993;151:1482-1490.
78. Lei L, Altstaedt J, von der OM, et al. Induction of interleukin-8 in human neutrophils after MHC class II cross-linking with superantigens. J Leukoc Biol. 2001;70:80-86.
79. Matsumoto S, Takei M, Moriyama M, Imanishi H. Enhancement of 1a-like antigen expression by interferon-gamma in polymorphonuclear leukocytes. Chem Pharm Bull (Tokyo). 1987;35:436-439.
80. Reinisch W, Lichtenberger C, Steger G, et al. Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo. Clin Exp Immunol. 2003;133:476-484.
81. Nishimura M, Mitsunaga S, Ishikawa Y, Satake M. Possible mechanisms underlying development of transfusion-related acute lung injury: roles of anti-major histocompatibility complex class II DR antibody. Transfus Med. 2003;13:141-147.
82. Porretti L, Coluccio E, Prati D, et al. Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report. Eur J Haematol. 2004;73:295-299.
83. Kopko PM, Popovsky MA. Pulmonary injury from transfusion-related acute lung injury. Clin Chest Med. 2004;25:105-111.
84. Leavey PJ, Sellins KS, Thurman G, et al. In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro. Blood. 1998;92:4366-4374.
85. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8:504-512.
86. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.
87. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol. 1994;55:662-675.
88. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 1994;124:684-694.
89. Silliman CC, Dickey WO, Paterson AJ, et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion. 1996;36:133-139.
90. Silliman CC, Elzi DJ, Ambruso DR, et al. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol. 2003;73:511-524.
91. Wyman TH, Bjornsen AJ, Elzi DJ, et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol. 2002;283:C1592-C1603.
92. Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion. 2003;43:633-640.
93. Sheppard R, Moore EE, Ryder J, et al. "Primed" human neutrophils on a standard peripheral blood smear. J Am Coll Surg. 2002;195:731.
94. Kopko PM, Curtis BR, Kelher M, McLaughlin N, Silliman CC. Merging the pathogenesis of transfusion-related acute lung injury: the priming activity of the 5b (HNA-3) antibody [abstract]. Transfusion. 2004;44:22.
95. Spiess BD, Royston D, Levy JH, et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion. 2004;44:1143-1148.
96. Goodnough LT, Johnston MF, Toy PT. The variability of transfusion practice in coronary artery bypass surgery: Transfusion Medicine Academic Award Group. JAMA. 1991;265:86-90.
97. Goodnough LT, Soegiarso RW, Birkmeyer JD, Welch HG. Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. Am J Med. 1993;94:509-514.
98. Surgenor DM, Wallace EL, Churchill WH, et al. Red cell transfusions in coronary artery bypass surgery (DRGs 106 and 107). Transfusion. 1992;32:458-464.
99. Palfi M, Berg S, Ernerudh J, Berlin G. A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion. 2001;41:317-322.
100. Benjamin RJ, Roggeveen B, Reeves C, Kelly ME. TRALI: components from female donors are not disproportionately involved in common transfusion reactions [abstract]. Transfusion. 2004;44:34.
101. Densmore TL, Goodnough LT, Ali S, Dynis M, Chaplin H. Prevalence of HLA sensitization in female apheresis donors. Transfusion. 1999;39:103-106.
102. Silliman CC, Moore EE, Johnson JL, Gonzalez RJ, Biffl WL. Transfusion of the injured patient: proceed with caution. Shock. 2004;21:291-299.
103. Insunza A, Romon I, Gonzalez-Ponte ML, et al. Implementation of a strategy to prevent TRALI in a regional blood centre. Transfus Med. 2004;14:157-164.
104. Dry SM, Bechard KM, Milford EL, Churchill WH, Benjamin RJ. The pathology of transfusion-related acute lung injury. Am J Clin Pathol. 1999;112:216-221.